Newman Dignan & Sheerar Inc’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.39M Sell
21,236
-128
-0.6% -$29.8K 1.03% 27
2026
Q1
$5.22M Sell
21,364
-737
-3% -$172K 1.1% 24
2025
Q4
$4.57M Buy
22,101
+381
+2% +$75.3K 0.95% 25
2025
Q3
$4.03M Sell
21,720
-1,214
-5% -$208K 0.87% 28
2025
Q2
$3.5M Buy
+22,934
New +$3.53M 0.81% 31
2025
Q1
Sell
-23,312
Closed -$3.37M 181
2024
Q4
$3.37M Sell
23,312
-1,110
-5% -$172K 0.86% 29
2024
Q3
$3.95M Buy
24,422
+13
+0.1% +$2.07K 0.95% 27
2024
Q2
$3.57M Sell
24,409
-220
-0.9% -$32.7K 0.92% 26
2024
Q1
$3.9M Sell
24,629
-1,020
-4% -$162K 1.04% 26
2023
Q4
$4.02M Buy
25,649
+390
+2% +$59.8K 1.21% 21
2023
Q3
$3.93M Sell
25,259
-970
-4% -$160K 1.29% 19
2023
Q2
$4.34M Sell
26,229
-213
-0.8% -$34.4K 1.34% 18
2023
Q1
$4.1M Sell
26,442
-2,874
-10% -$464K 1.32% 17
2022
Q4
$5.18M Sell
29,316
-27
-0.1% -$4.66K 1.72% 13
2022
Q3
$4.79K Buy
29,343
+66
+0.2% +$11.2K 0.75% 13
2022
Q2
$5.2M Sell
29,277
-368
-1% -$65.6K 1.77% 12
2022
Q1
$5.25K Sell
29,645
-7
-0% -$1.19K 1.01% 14
2021
Q4
$5.07M Sell
29,652
-393
-1% -$64.3K 1.54% 13
2021
Q3
$4.85M Buy
30,045
+91
+0.3% +$15.5K 1.4% 14
2021
Q2
$4.93M Sell
29,954
-103
-0.3% -$17.1K 1.66% 13
2021
Q1
$4.94M Buy
30,057
+211
+0.7% +$34.1K 1.79% 14
2020
Q4
$4.7K Sell
29,846
-645
-2% -$95.2K 0.76% 15
2020
Q3
$4.54M Buy
30,491
+57
+0.2% +$8.43K 1.9% 12
2020
Q2
$4.47M Sell
30,434
-276,590
-90% -$40.3M 1.93% 13
2020
Q1
$4.53M Buy
307,024
+275,434
+872% +$39.1M 2.37% 9
2019
Q4
$4.61K Sell
31,590
-584
-2% -$79.2K 0.49% 16
2019
Q3
$4.16M Sell
32,174
-1,047
-3% -$138K 1.96% 12
2019
Q2
$4.63K Sell
33,221
-198
-0.6% -$27.4K 0.12% 12
2019
Q1
$4.67M Sell
33,419
-1,908
-5% -$256K 1.88% 13
2018
Q4
$4.56K Buy
35,327
+162
+0.5% +$22.6K 0.39% 17
2018
Q3
$4.89M Buy
35,165
+398
+1% +$52.9K 2.14% 13
2018
Q2
$4.22K Buy
34,767
+87
+0.3% +$10.9K 0.28% 11
2018
Q1
$4.53M Sell
34,680
-662
-2% -$89.5K 2.29% 10
2017
Q4
$4.94M Sell
35,342
-784
-2% -$109K 2.47% 8
2017
Q3
$4.7M Sell
36,126
-359
-1% -$47.6K 2.5% 7
2017
Q2
$4.83M Buy
36,485
+218
+0.6% +$27.8K 2.68% 6
2017
Q1
$4.52K Sell
36,267
-869
-2% -$104K 2% 10
2016
Q4
$4.28M Sell
37,136
-250
-0.7% -$28.9K 2.61% 6
2016
Q3
$4.42M Buy
37,386
+285
+0.8% +$34.6K 2.78% 4
2016
Q2
$4.5M Sell
37,101
-254
-0.7% -$28.9K 2.81% 5
2016
Q1
$4.04M Buy
37,355
+61
+0.2% +$6.32K 2.94% 5
2015
Q4
$3.83M Buy
37,294
+236
+0.6% +$23.7K 2.71% 6
2015
Q3
$3.46M Buy
37,058
+882
+2% +$85.3K 2.22% 7
2015
Q2
$3.53M Buy
36,176
+71
+0.2% +$7.11K 2.54% 7
2015
Q1
$3.63M Sell
36,105
-594
-2% -$60.4K 2.59% 6
2014
Q4
$2.83K Hold
36,699
1.69% 11
2014
Q3
$3.91M Sell
36,699
-231
-0.6% -$24K 2.94% 3
2014
Q2
$3.86K Sell
36,930
-3,209
-8% -$324K 2.2% 9
2014
Q1
$3.94M Buy
40,139
+86
+0.2% +$7.97K 2.81% 4
2013
Q4
$3.67K Buy
40,053
+56
+0.1% +$5.16K 0.18% 6
2013
Q3
$3.47M Sell
39,997
-220
-0.5% -$19.7K 2.69% 5
2013
Q2
$3.45K Buy
+40,217
New +$3.41M 0.27% 7

Other funds holding JNJ

Newman Dignan & Sheerar Inc's JNJ Position: Q2 2026 in Review

Newman Dignan & Sheerar Inc reduced its Johnson & Johnson (JNJ) stake by 0.6% in Q2 2026, selling an estimated $29.8K and leaving 21,236 shares worth $5.39M. The position accounts for 1.03% of the portfolio, ranked #27.

Newman Dignan & Sheerar Inc first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Newman Dignan & Sheerar Inc held 21,236 shares of Johnson & Johnson worth $5.39M as of Q2 2026.
  • Newman Dignan & Sheerar Inc sold 128 Johnson & Johnson shares in Q2 2026, an estimated $29.8K.
  • Johnson & Johnson made up 1.03% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #27 holding.
  • Newman Dignan & Sheerar Inc first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.